End-of-life care (ELC), or comfort care, describes a robust array of healthcare practices for patients who have stopped ...
Around 21 million adults in the U.S. (8.4%) experienced a major depressive episode in 2023 and Medicare Part B recipients are ...
Drugmaker Merck said on Tuesday it expects its top selling cancer therapy Keytruda to be selected in 2026 for government ...
Millions of American women are at high risk for breast cancer, but their insurance does not cover the costs of extra ...
Many older adults with advanced cancer receive potentially aggressive treatment but not a lot of supportive care, according ...
Researchers analyzed 33,744 fee-for-service Medicare decedents with distant-stage breast, prostate, pancreatic, or lung cancers who died between 2014 and 2019.
One pharmacist drew attention to a massive pricing disparity on a key cancer drug, and that disparity may help to explain why ...
In addition to the coverage in NSCLC, Signatera is also covered by Medicare for adjuvant and recurrence monitoring in colorectal cancer, muscle-invasive bladder cancer, breast cancer, and ovarian ...
“Even though clinicians and professional healthcare organizations have recommended early integration of supportive and ...
Several key members of the Senate Finance Committee have reintroduced a bill that seeks to establish a Medicare coverage ...
Natera (NTRA) announced that its Signatera test has met coverage requirements from the Centers for Medicare & Medicaid Services’ Molecular ...